FDA Import Refusal 1FX-3323419-6/10002/6 — ASCEND LABORATORIES SPA
The FDA refused shipment 1FX-3323419-6/10002/6 from ASCEND LABORATORIES SPA (Chile) on July 7, 2026. The refused product falls under Drugs and Biologics — GABAPENTIN (ANTI-DEPRESSANT). Cited charge: 75 This firm has 2 other import refusals on record.
Refusal Details
- Date
- July 7, 2026
- Country
- Chile
- Product Category
- Drugs and Biologics
- Product Code
- 61NDA69 GABAPENTIN (ANTI-DEPRESSANT)
- Charges
- 75